Stephen E. Ettinghausen
Impact in
- Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 14
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 4
- Cytokine Signaling Pathways and Interactions 3
- Immunology 14
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 7
- Co-authors
- Steven A. Rosenberg (16 shared papers)Michael T. Lotze (3 shared papers)Yvedt L. Matory (3 shared papers)Claudia A. Seipp (3 shared papers)John T. Vetto (3 shared papers)Cheryl M. Reichert (1 shared paper)John M. Skibber (1 shared paper)Linda Muul (1 shared paper)
- Journals
- The Journal of Immunology (5 papers)Journal of Clinical Oncology (3 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer (2 papers)Human Gene Therapy (2 papers)
- Partner nations
- United StatesMalaysiaFrance
In The Last Decade
Stephen E. Ettinghausen
33 papers receiving 5.1k citations
Stephen E. Ettinghausen's Hit Papers
Peers
Comparison fields: 5 of 117
- Immunology 2.8k
- Oncology 2.1k
- Hematology 397
- Rheumatology 335
- Biotechnology 175
Countries citing papers authored by Stephen E. Ettinghausen
This map shows the geographic impact of Stephen E. Ettinghausen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Ettinghausen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Ettinghausen more than expected).
Fields of papers citing papers by Stephen E. Ettinghausen
This network shows the impact of papers produced by Stephen E. Ettinghausen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Ettinghausen. The network helps show where Stephen E. Ettinghausen may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen E. Ettinghausen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer Hit paper breakdown → | 1985 | 2148 |
| 2 | In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. Hit paper breakdown → | 1985 | 524 |
| 3 | Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. Hit paper breakdown → | 1986 | 471 |
| 4 | 1986 | 310 | |
| 5 | 2006 | 272 | |
| 6 | Pseudomyxoma peritonei syndrome. | 1996 | 215 |
| 7 | 1993 | 190 | |
| 8 | 1991 | 138 | |
| 9 | 1985 | 133 | |
| 10 | 1994 | 132 | |
| 11 | 1985 | 122 | |
| 12 | 1988 | 108 | |
| 13 | Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2. | 1986 | 96 |
| 14 | Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice. | 1986 | 63 |
| 15 | Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. | 1986 | 63 |
| 16 | 1993 | 57 | |
| 17 | 1994 | 50 | |
| 18 | Localization of an occult insulinoma by intraoperative ultrasonography. | 1985 | 46 |
| 19 | 1992 | 43 | |
| 20 | 1993 | 40 |
About Stephen E. Ettinghausen
Stephen E. Ettinghausen is a scholar working on Oncology, Immunology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 35 papers that have together received 5.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Virus-based gene therapy research (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Immunology (2.8k citations), Oncology (2.1k citations), Hematology (397 citations), Rheumatology (335 citations) and Biotechnology (175 citations). Stephen E. Ettinghausen has collaborated with scholars based in United States, Malaysia and France. Frequent co-authors include Steven A. Rosenberg, Michael T. Lotze, Yvedt L. Matory, Claudia A. Seipp, John T. Vetto, Cheryl M. Reichert, John M. Skibber, Linda Muul, Alfred E. Chang and Eitan Shiloni. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Cancer and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.